{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:43:34Z","timestamp":1793832214378,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key R & D Program of China","award":["2018YFC1002103"],"award-info":[{"award-number":["2018YFC1002103"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81701521"],"award-info":[{"award-number":["No.81701521"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recent studies have consistently shown that AFC and serum AMH are good predictors of ovarian response and have shown strong correlations. However, it is not unusual for reproductive medicine specialists to encounter discordance between them. This is the first study to investigate the efficacies of the different COS protocols when the AFC and AMH levels are discordant. Based on the association between COS protocols and pregnancy outcomes, we attempt to explain the controversial results and clarify the predictive value of AMH and AFC in this context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>19,239 patients undergoing their first fresh in vitro fertilization (IVF)\/intracytoplasmic sperm injection (ICSI) cycles with GnRH antagonist protocols, GnRH-a long protocols or GnRH-a ultra-long protocols between January 1, 2016, and December 31, 2019, were enrolled and then divided into four groups in accordance with the boundaries for the AFC and serum AMH level provided by the Poseidon Classification. Our study was divided into two parts. Firstly, we retrospectively compared the effects of the three COS protocols in patients with discordant AMH and AFC. Multivariate logistic regression models were conducted in a forward manner to exclude the influence of confounding factors. Afterward, to increase comparability between Group 2 (low AMH and normal AFC) and Group 3 (normal AMH and low AFC), propensity score matching (PSM) analysis was performed based on age, BMI, the number of embryos transferred, and COS protocol. IVF intermediate and reproductive outcomes were compared between Group 2 and Group 3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>For people with low AMH and normal AFC (Group 2), the number of total oocytes, clinical pregnancy rate (CPR), live birth rate (LBR) and cumulative live birth rate (CLBR) were significantly higher in GnRH-a ultra-long protocol compared with GnRH antagonist protocol. In multivariate logistic regression models, significant associations of COS protocol with fresh LBR and CPR were found after adjusting for age, BMI, AFC, AMH and the number of embryos transferred. Whereas, in patients with normal AMH and low AFC (Group 3), the number of total oocytes, CLBR, LBR and CPR were highest in the long GnRH-a protocol although there was no statistically significant difference. After PSM, the results showed that although oocytes yield and available embryos in patients with normal AMH and low AFC were significantly higher, there was no significant difference in reproductive outcomes between Group 2 and Group 3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found that women with normal AFC and low AMH may benefit from the GnRH-a ultra-long protocol. Nevertheless, for women with normal AMH and low AFC, the long GnRH-a protocol seems to be associated with better clinical outcomes. Furthermore, after eliminating the confounding factors including the COS protocol, we found that AMH can only predict the number of oocytes but not the quality of oocytes when there was discordance between AFC and AMH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-021-00863-4","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T12:02:34Z","timestamp":1630152154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients"],"prefix":"10.1186","volume":"14","author":[{"given":"Yaxin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huahua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6440-4835","authenticated-orcid":false,"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,28]]},"reference":[{"issue":"1","key":"863_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/humupd\/dmt037","volume":"20","author":"A La Marca","year":"2014","unstructured":"La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update. 2014;20(1):124\u201340.","journal-title":"Hum Reprod Update"},{"key":"863_CR2","doi-asserted-by":"publisher","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2015 Mar;103(3):e9-e17. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.12.093. Epub 2015 Jan 10.","DOI":"10.1016\/j.fertnstert.2014.12.093"},{"issue":"3","key":"863_CR3","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","volume":"91","author":"SL Broer","year":"2009","unstructured":"Broer SL, Mol BWJ, Hendriks D, Broekmans FJM. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91(3):705\u201314.","journal-title":"Fertil Steril"},{"issue":"1","key":"863_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/humupd\/dmq034","volume":"17","author":"SL Broer","year":"2011","unstructured":"Broer SL, D\u00f3lleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJM. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17(1):46\u201354.","journal-title":"Hum Reprod Update"},{"key":"863_CR5","doi-asserted-by":"crossref","unstructured":"Tal R, Seifer DB. Ovarian reserve testing: a user's guide. Am J Obstet Gynecol. 2017;217(2):129\u201340.","DOI":"10.1016\/j.ajog.2017.02.027"},{"issue":"2","key":"863_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113\u201330.","journal-title":"Hum Reprod Update"},{"key":"863_CR7","doi-asserted-by":"crossref","unstructured":"Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616\u201324.","DOI":"10.1093\/humrep\/der092"},{"issue":"6","key":"863_CR8","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","volume":"105","author":"C Alviggi","year":"2016","unstructured":"Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452\u20133.","journal-title":"Fertil Steril"},{"issue":"2","key":"863_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/humrep\/deg042","volume":"18","author":"R Fanchin","year":"2003","unstructured":"Fanchin R, Schon\u00e4uer LM, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-M\u00fcllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 2003;18(2):323\u20137.","journal-title":"Hum Reprod"},{"issue":"8","key":"863_CR10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1080\/09513590701532815","volume":"23","author":"LG Nardo","year":"2007","unstructured":"Nardo LG, Christodoulou D, Gould D, Roberts SA, Fitzgerald CT, Laing I. Anti-M\u00fcllerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: relationship to lifestyle factors, chronological age and reproductive history. Gynecol Endocrinol. 2007;23(8):486\u201393.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"863_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/gme.0b013e3181ef5a78","volume":"18","author":"YS Yang","year":"2011","unstructured":"Yang YS, Hur MH, Kim SY, Young K. Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition. Menopause. 2011;18(2):138\u201345.","journal-title":"Menopause"},{"key":"863_CR12","doi-asserted-by":"publisher","unstructured":"Leonhardt H, Hellstr\u00f6m M, Gull B, Lind AK, Nilsson L, Janson PO, Stener-Victorin E. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antim\u00fcllerian hormone, free testosterone, and glucose disposal rate. Fertil Steril. 2014;101(6):1747\u201356.e1\u20133. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.02.022. Epub 2014 Mar 21.","DOI":"10.1016\/j.fertnstert.2014.02.022"},{"issue":"1","key":"863_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12958-019-0497-4","volume":"17","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Xu Y, Xue Q, Shang J, Yang X, Shan X, et al. Discordance between antral follicle counts and anti-M\u00fcllerian hormone levels in women undergoing in vitro fertilization. Reprod Biol Endocrinol. 2019;17(1):51.","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"863_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1093\/humrep\/dey098","volume":"33","author":"M\u0160 Alebic","year":"2018","unstructured":"Alebic M\u0160, Stojanovic N, Dewailly D. Discordance between serum anti-M\u00fcllerian hormone concentrations and antral follicle counts: not only technical issues. Hum Reprod. 2018;33(6):1141\u20138.","journal-title":"Hum Reprod"},{"key":"863_CR15","doi-asserted-by":"publisher","unstructured":"Mochtar MH, Van der Veen, Ziech M, van Wely M. Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 2007;5:CD005070. https:\/\/doi.org\/10.1002\/14651858.CD005070.pub2.","DOI":"10.1002\/14651858.CD005070.pub2"},{"issue":"6","key":"863_CR16","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0015-0282(16)55968-8","volume":"59","author":"Z Shoham","year":"1993","unstructured":"Shoham Z, Jacobs HS, Insler V. Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril. 1993;59(6):1153\u201361.","journal-title":"Fertil Steril"},{"issue":"4","key":"863_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.rbmo.2015.06.015","volume":"31","author":"R Fleming","year":"2015","unstructured":"Fleming R, Seifer DB, Frattarelli JL, Ruman J. Assessing ovarian response: antral follicle count versus anti-M\u00fcllerian hormone. Reprod Biomed Online. 2015;31(4):486\u201396.","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"863_CR18","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1093\/humrep\/deaa086","volume":"35","author":"B Xu","year":"2020","unstructured":"Xu B, Geerts D, Hu S, Yue J, Li Z, Zhu G, et al. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study. Hum Reprod. 2020;35(6):1306\u201318.","journal-title":"Hum Reprod"},{"key":"863_CR19","doi-asserted-by":"publisher","unstructured":"Pan W, Tu H, Jin L, Hu C, Li Y, Wang R, Huang W, Liao S. Decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient. Medicine (Baltimore). 2019;98(19):e15492. https:\/\/doi.org\/10.1097\/MD.0000000000015492.","DOI":"10.1097\/MD.0000000000015492"},{"key":"863_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.reprotox.2016.04.005","volume":"61","author":"Y-Y Du","year":"2016","unstructured":"Du Y-Y, Fang Y-L, Wang Y-X, Zeng Q, Guo N, Zhao H, et al. Follicular fluid and urinary concentrations of phthalate metabolites among infertile women and associations with in vitro fertilization parameters. Reprod Toxicol. 2016;61:142\u201350.","journal-title":"Reprod Toxicol"},{"key":"863_CR21","doi-asserted-by":"publisher","unstructured":"Huang B, Ren X, Wu L, Zhu L, Xu B, Li Y, Ai J, Jin L. Elevated Progesterone Levels on the Day of Oocyte Maturation May Affect Top Quality Embryo IVF Cycles. PLoS One. 2016;11(1):e0145895. https:\/\/doi.org\/10.1371\/journal.pone.0145895.","DOI":"10.1371\/journal.pone.0145895"},{"issue":"2","key":"863_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.rbmo.2013.04.006","volume":"27","author":"L Zhu","year":"2013","unstructured":"Zhu L, Xi Q, Zhang H, Li Y, Ai J, Jin L. Blastocyst culture and cryopreservation to optimize clinical outcomes of warming cycles. Reprod Biomed Online. 2013;27(2):154\u201360.","journal-title":"Reprod Biomed Online"},{"key":"863_CR23","doi-asserted-by":"publisher","unstructured":"Cobo A, de los Santos MJ, Castell\u00f2 D, G\u00e1miz P, Campos P, Remoh\u00ed J. Outcomes of vitrified early cleavage-stage and blastocyst-stage embryos in a cryopreservation program: evaluation of 3,150 warming cycles. Fertil Steril. 2012;98(5):1138\u201346.e1. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.07.1107. Epub 2012 Aug 3.","DOI":"10.1016\/j.fertnstert.2012.07.1107"},{"key":"863_CR24","doi-asserted-by":"publisher","unstructured":"Albuquerque LE, Tso LO, Saconato H, Albuquerque MC, Macedo CR. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles. Cochrane Database Syst Rev. 2013;2013(1):CD002808. https:\/\/doi.org\/10.1002\/14651858.CD002808.pub3.","DOI":"10.1002\/14651858.CD002808.pub3"},{"issue":"3","key":"863_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20(3):370\u201385.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"863_CR26","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.fertnstert.2012.11.051","volume":"99","author":"SM Nelson","year":"2013","unstructured":"Nelson SM. Biomarkers of ovarian response: current and future applications. Fertil Steril. 2013;99(4):963\u20139.","journal-title":"Fertil Steril"},{"key":"863_CR27","doi-asserted-by":"publisher","unstructured":"Nelson SM, Klein BM, Arce JC. Comparison of antim\u00fcllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials. Fertil Steril. 2015;103(4):923\u201330.e1. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.12.114. Epub 2015 Jan 24.","DOI":"10.1016\/j.fertnstert.2014.12.114"},{"issue":"3","key":"863_CR28","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.fertnstert.2009.04.040","volume":"94","author":"FJM Broekmans","year":"2010","unstructured":"Broekmans FJM, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010;94(3):1044\u201351.","journal-title":"Fertil Steril"},{"issue":"6","key":"863_CR29","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/humupd\/dmu062","volume":"21","author":"S Iliodromiti","year":"2015","unstructured":"Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-M\u00fcllerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update. 2015;21(6):698\u2013710.","journal-title":"Hum Reprod Update"},{"issue":"7","key":"863_CR30","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.fertnstert.2013.03.001","volume":"99","author":"JP Toner","year":"2013","unstructured":"Toner JP, Seifer DB. Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antim\u00fcllerian hormone. Fertil Steril. 2013;99(7):1825\u201330.","journal-title":"Fertil Steril"},{"issue":"1","key":"863_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/humupd\/dms043","volume":"19","author":"SM Nelson","year":"2013","unstructured":"Nelson SM, Telfer EE, Anderson RA. The ageing ovary and uterus: new biological insights. Hum Reprod Update. 2013;19(1):67\u201383.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"863_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/humrep\/dep366","volume":"25","author":"J van Disseldorp","year":"2010","unstructured":"van Disseldorp J, Lambalk CB, Kwee J, Looman CWN, Eijkemans MJC, Fauser BC, et al. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod. 2010;25(1):221\u20137.","journal-title":"Hum Reprod"},{"key":"863_CR33","doi-asserted-by":"publisher","unstructured":"Li HW, Lee VC, Lau EY, Yeung WS, Ho PC, Ng EH. Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study. PLoS One. 2014;9(10):e108493. https:\/\/doi.org\/10.1371\/journal.pone.0108493.","DOI":"10.1371\/journal.pone.0108493"},{"issue":"10","key":"863_CR34","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1093\/humrep\/del215","volume":"21","author":"H-C Ruan","year":"2006","unstructured":"Ruan H-C, Zhu X-M, Luo Q, Liu A-X, Qian Y-L, Zhou C-Y, et al. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice. Hum Reprod. 2006;21(10):2521\u20139.","journal-title":"Hum Reprod"},{"issue":"5","key":"863_CR35","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","volume":"23","author":"CB Lambalk","year":"2017","unstructured":"Lambalk CB, Banga FR, Huirne JA, Toftager M, Pinborg A, Homburg R, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017;23(5):560\u201379.","journal-title":"Hum Reprod Update"},{"key":"863_CR36","doi-asserted-by":"publisher","unstructured":"Al-Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2016;4:CD001750. https:\/\/doi.org\/10.1002\/14651858.CD001750.pub4.","DOI":"10.1002\/14651858.CD001750.pub4"},{"key":"863_CR37","doi-asserted-by":"publisher","unstructured":"Xiao JS, Su CM, Zeng XT. Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis. PLoS One. 2014;9(9):e106854. https:\/\/doi.org\/10.1371\/journal.pone.0106854.","DOI":"10.1371\/journal.pone.0106854"},{"issue":"6","key":"863_CR38","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/humrep\/dew051","volume":"31","author":"M Toftager","year":"2016","unstructured":"Toftager M, Bogstad J, Bryndorf T, L\u00f8ssl K, Rosk\u00e6r J, Holland T, et al. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles. Hum Reprod. 2016;31(6):1253\u201364.","journal-title":"Hum Reprod"},{"key":"863_CR39","doi-asserted-by":"publisher","unstructured":"Wang R, Lin S, Wang Y, Qian W, Zhou L. Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: a systematic review and meta-analysis. PLoS One. 2017;12(4):e0175985. https:\/\/doi.org\/10.1371\/journal.pone.0175985.","DOI":"10.1371\/journal.pone.0175985"},{"issue":"9742","key":"863_CR40","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0140-6736(10)60490-4","volume":"376","author":"D de Ziegler","year":"2010","unstructured":"de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet (London, England). 2010;376(9742):730\u20138.","journal-title":"Lancet (London, England)"},{"issue":"1","key":"863_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12958-020-00571-6","volume":"18","author":"X Cao","year":"2020","unstructured":"Cao X, Chang H-Y, Xu J-Y, Zheng Y, Xiang Y-G, Xiao B, et al. The effectiveness of different down-regulating protocols on in vitro fertilization-embryo transfer in endometriosis: a meta-analysis. Reprod Biol Endocrinol. 2020;18(1):16.","journal-title":"Reprod Biol Endocrinol"},{"key":"863_CR42","doi-asserted-by":"publisher","unstructured":"Liu S, Xie Y, Li F, Jin L. Effectiveness of ultra-long protocol on in vitro fertilization\/intracytoplasmic sperm injection-embryo transfer outcome in infertile women with endometriosis: A systematic review and meta-analysis of randomized controlled trials. J Obstet Gynaecol Res. 2021;47(4):1232\u201342. https:\/\/doi.org\/10.1111\/jog.14630. Epub 2021 Jan 11.","DOI":"10.1111\/jog.14630"},{"issue":"3","key":"863_CR43","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s12020-012-9706-z","volume":"42","author":"N Liu","year":"2012","unstructured":"Liu N, Ma Y, Li R, Jin H, Li M, Huang X, et al. Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols. Endocrine. 2012;42(3):708\u201316.","journal-title":"Endocrine"},{"key":"863_CR44","doi-asserted-by":"publisher","unstructured":"Shen X, Gao H, Chen Q, Cai R, Lyu Q, Wang Y, Wang L, Kuang Y. Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures. Med Sci Monit. 2020;26:e918705. https:\/\/doi.org\/10.12659\/MSM.918705.","DOI":"10.12659\/MSM.918705"},{"key":"863_CR45","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3389\/fendo.2019.00892","volume":"10","author":"Y-X Lee","year":"2019","unstructured":"Lee Y-X, Shen M-S, Tzeng C-R. Low Dose Growth Hormone Adjuvant Treatment With Ultra-Long Ovarian Stimulation Protocol in Poor Responders Showed Non-inferior Pregnancy Outcome Compared With Normal Responders. Front Endocrinol (Lausanne). 2019;10:892.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"863_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/09513590.2013.860121","volume":"30","author":"J Tu","year":"2014","unstructured":"Tu J, Lin G, Lu C, Gong F. A novel modified ultra-long agonist protocol improves the outcome of high body mass index women with polycystic ovary syndrome undergoing IVF\/ICSI. Gynecol Endocrinol. 2014;30(3):209\u201312.","journal-title":"Gynecol Endocrinol"},{"issue":"12","key":"863_CR47","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1093\/humrep\/der318","volume":"26","author":"AN Andersen","year":"2011","unstructured":"Andersen AN, Witjes H, Gordon K, Mannaerts B. Predictive factors of ovarian response and clinical outcome after IVF\/ICSI following a rFSH\/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Hum Reprod. 2011;26(12):3413\u201323.","journal-title":"Hum Reprod"},{"issue":"6","key":"863_CR48","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","volume":"99","author":"J-C Arce","year":"2013","unstructured":"Arce J-C, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R. Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Fertil Steril. 2013;99(6):1644\u201353.","journal-title":"Fertil Steril"},{"issue":"2","key":"863_CR49","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.fertnstert.2013.04.029","volume":"100","author":"NP Polyzos","year":"2013","unstructured":"Polyzos NP, Tournaye H, Guzman L, Camus M, Nelson SM. Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization\/intracytoplasmic sperm injection. Fertil Steril. 2013;100(2):430\u20137.","journal-title":"Fertil Steril"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-021-00863-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-021-00863-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-021-00863-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T12:03:06Z","timestamp":1630152186000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-021-00863-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,28]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["863"],"URL":"https:\/\/doi.org\/10.1186\/s13048-021-00863-4","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,28]]},"assertion":[{"value":"21 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this study was obtained from the Institutional Review Board of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}